Literature DB >> 36254088

Current status and trends of pulmonary rehabilitation in South Korea: National level data analysis using Health Insurance Review and Assessment Service (HIRA) database from 2016 to 2018.

Hyo-Jung Kim1, Hee-Eun Choi2, Hang-Jea Jang1, Hyun-Kuk Kim1, Jin-Han Park1, Jae-Ha Lee1, Tae-Hoon Kim2.   

Abstract

In South Korea, there are few studies to understand the current status of pulmonary rehabilitation in clinical practice and develop it. This study aimed to assess the current status and annual changes in the number and pattern of prescriptions for pulmonary rehabilitation before and after its insurance coverage. The trends of pulmonary rehabilitation before and after its insurance coverage commencement were evaluated using the data of 24,380 patients during the 3-year period from 2016 to 2018 that were archived by the National Health Information Database of the Health Insurance Review and Assessment Service in South Korea. The annual total number of patients who received pulmonary rehabilitation was stratified by the type of prescription, sex, age, type of insurance, medical institution, and region. In addition, the frequencies of pulmonary rehabilitation for various diagnoses were investigated using the major codes of the Korean Standard Classification of Disease. The patients who received pulmonary rehabilitation increased by approximately 2 times from 5936 in 2016 (before insurance coverage) to 10,474 in 2019. Before 2017, most patients underwent simple pulmonary rehabilitation coded as MM290. However, since the insurance coverage of rehabilitation exercise for pulmonary disease (MM440), the proportions of patients receiving them increased. Men underwent pulmonary rehabilitation more often than women, and >70% of the patients were aged >60 years. Most patients received pulmonary rehabilitation at tertiary hospitals in Seoul. In 2016, pulmonary rehabilitation was prescribed more frequently for cerebral infarction; after 2017, it was prescribed more frequently for lung cancer. This study summarized the current status and trends of pulmonary rehabilitation in South Korea before and after National Health Insurance Service coverage, which commenced on January 1, 2017. A significant increase in the number of pulmonary rehabilitations was confirmed after the insurance coverage.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2022        PMID: 36254088      PMCID: PMC9575737          DOI: 10.1097/MD.0000000000031085

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  19 in total

1.  National pulmonary rehabilitation survey. Update.

Authors:  L S Bickford; J E Hodgkin; S L McInturff
Journal:  J Cardiopulm Rehabil       Date:  1995 Nov-Dec       Impact factor: 2.081

2.  Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease.

Authors:  S Foster; H M Thomas
Journal:  Am Rev Respir Dis       Date:  1990-03

Review 3.  Pulmonary Rehabilitation in Individuals With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review.

Authors:  Annemarie L Lee; Catherine J Hill; Christine F McDonald; Anne E Holland
Journal:  Arch Phys Med Rehabil       Date:  2016-06-16       Impact factor: 3.966

4.  Pulmonary rehabilitation in Australia: a national survey.

Authors:  Catherine L Johnston; Lyndal J Maxwell; Jennifer A Alison
Journal:  Physiotherapy       Date:  2011-02-02       Impact factor: 3.358

5.  Efficacy of pulmonary rehabilitation in improving the quality of life for patients with chronic obstructive pulmonary disease: Evidence based on nineteen randomized controlled trials.

Authors:  Jige Dong; Zhanjun Li; Lihua Luo; Hongzhi Xie
Journal:  Int J Surg       Date:  2019-12-13       Impact factor: 6.071

6.  Pulmonary Rehabilitation and Improved Survival for Patients With COPD.

Authors:  Carolyn L Rochester; Anne E Holland
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

7.  The Effect of Pulmonary Rehabilitation on Non-chronic Obstructive Pulmonary Disease Patients.

Authors:  Ariel Rokach; Ayal Romem; Nissim Arish; Hava Azulai; Chen Chen; Milka Bertisch; Gabriel Izbicki
Journal:  Isr Med Assoc J       Date:  2019-05       Impact factor: 0.892

Review 8.  How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD.

Authors:  Anne E Holland; Karin Wadell; Martijn A Spruit
Journal:  Eur Respir Rev       Date:  2013-12

9.  Pulmonary rehabilitation programmes in the UK: a national representative survey.

Authors:  Abebaw M Yohannes; Martin J Connolly
Journal:  Clin Rehabil       Date:  2004-06       Impact factor: 3.477

Review 10.  Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data.

Authors:  Jee Ae Kim; Seokjun Yoon; Log Young Kim; Dong Sook Kim
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.